Introduction {#sec1-1}
============

Obstructive sleep apnea (OSA) is characterized by recurrent upper airway obstruction during sleep, resulting in decreased oxygenation inducing arousal from sleep.\[[@ref1]\] The prevalence of OSA in the general population ranges from 9% to 38%, with obesity, aging, and male sex showing the highest incidence as related factors.\[[@ref2]\] However, 82% of men and 93% of women remain undiagnosed. These cases, however, are clinically significant, indicating that the proportion of OSA may be much higher than expected.\[[@ref3]\] In Saudi Arabia, the overall prevalence of obesity is 35.4%, and the country ranks 14^th^ in the world with regard to the prevalence of obesity.\[[@ref4]\]

Many studies have shown that obesity influences the severity of OSA. One such study conducted in Chile with 916 participants reported a significant association between general and central obesity and high OSA risk.\[[@ref5]\] Another study done in Turkey on 499 patients who were diagnosed with OSA found that the risk of OSA was roughly proportional to the circumference of the upper neck.\[[@ref6]\] This association is likely because high-fat accumulation in a patient\'s neck can weaken the pharyngeal muscle and decrease the pharyngeal cross-sectional area. Hence, obstruction of the upper airway, particularly while sleeping, is expected.\[[@ref7]\] Furthermore, a study in Italy on 161 obese patients which examined the prevalence of sleep breathing disorders in these subjects demonstrated that \>50% of the patients with a mean BMI higher than 40.0 kg/m^2^ had OSA. Moreover, there appears to be an even higher percentage for women. In fact, the neck circumference of men and BMI of women seem to be the strongest and the most reliable predictive factors for the severity of OSA in obese patients.\[[@ref8]\]

At present, the global burden of diseases and disabilities is dramatically affected by obesity, and the prevalence of obesity even in adolescents and children has significantly increased in the last few decades.\[[@ref9][@ref10]\] Hence, this study was to assess the relationship between OSA and BMI in patients attending the sleep center of King Abdulaziz University Hospital (KAUH) and estimate the effect of obesity on the severity of the disease.

Materials and Methods {#sec1-2}
=====================

This cross-sectional study was conducted among all patients referred to the sleep center of KAUH and had undergone polysomnography (PSG) between January 2012 and September 2017. The data were abstracted from the medical records of all these patients. KAUH is one of the biggest tertiary and referral centers in the western region of Saudi Arabia, with a capacity of 800 beds. The study was approved by the institutional review board, and written informed consent was obtained from all study participants.

A total of 878 patients referred to the sleep center of KAUH had undergone polysomnography (PSG) during the study period. Seventy five patients were excluded because of noninterpretable or missing data, such as BMI and apnea--hypopnea index (AHI) in the PSG report.

PSG is the standard test for the diagnosis of OSA in adult patients\[[@ref11]\] and is used to diagnose and monitor sleep disorders related to breathing and movement or neurological causes. Respiratory parameters were collected, including AHI and minimum O~2~ saturation during sleep (%). The AHI was determined as the number of apnea and hypopnea events per hour recorded during sleep. Apnea was defined as complete cessation of breathing during an interval of 10 s or more, while hypopnea is defined as a decrease of at least 30% in airflow, accompanied by a decrease in oxygen saturation of 4% or greater, with chest and abdominal movement. Patients who had an AHI of five episodes per hour or more were defined as having OSA.\[[@ref2]\] Regarding the severity of OSA, an AHI of 5--14.9 events/h was considered mild, an AHI between 15 and 29.9 events/h was moderate, and an AHI of 30 events/h or more was considered severe.

The coordinator of sleep medicine and research center in the hospital gave the details of the PSG procedure, as applied in KAUH. Initially, a pretest questionnaire is given to the patient, and the procedure will be explained in detail. The patient is then admitted to the sleep center and tested with continuous monitoring of the vital signs. Observations made by a technician during the PSG are recorded in the technician\'s notes. The recordings are paused if the study is interrupted at any time. According to the KAUH protocol, the test is terminated when the patient wakes up and is unable to fall asleep again; otherwise, the test ends at 6:00 AM. At the end of the procedure, the patient is disconnected from the machine and discharged after the completion of a postsleep study questionnaire. The patient is given an appointment in the sleep disorder clinics, 2 weeks after the test, for a follow-up on the results.

For the study, body measurements including the height, measured to the nearest centimeter, and the weight, measured without shoes, were extracted from the PSG reports of the patients. Height and weight are measured routinely on hospital admissions and in the clinics. These measurements are taken by an experienced nurse staff who follows a stringent hospital protocol of taking accurate weight measurement to the nearest kilogram, using a balance beam scale. BMI was calculated by dividing the individual\'s weight, in kilograms (kg), by the square of the body height, in meters (m). Subjects were grouped into four BMI categories: underweight (\<18.5 kg/m^2^), normal weight (18.5--24.9 kg/m^2^), overweight (25.0--29.9 kg/m^2^), and obese (\>30.0 kg/m^2^). Patients in the obese category were grouped into three classes: BMI between 30 and 34.99 was defined as Class 1, BMI between 35 and 39.99 was defined as Class 2, and BMI higher than 39.99 was defined as Class 3.\[[@ref12]\] Laboratory results for the patients, including glycosylated hemoglobin, triglyceride, high-density lipoprotein, and low-density lipoprotein, as well as demographic data such as age and sex were included in the analyses to look for possible associations between these variables and different classes of BMI.

The data were analyzed using Statistical Package for the Social Sciences (SPSS) version 23 (IBM Corp., Armonk, NY, USA). Descriptive analyses included frequency distribution and percentages for categorical variables; mean and standard deviations computed for continuous variables. Chi-square test, *t*-test, and one-way ANOVA, as appropriate, were used to assess the associations between the variables. All tests were performed at 5% level of significance.

Results {#sec1-3}
=======

A total of 803 patients were included in the study. The demographic/clinical and Laboratory results for study participants are presented in [Table 1](#T1){ref-type="table"}. The mean age of the patients was 45.9 years, and 56.5% were male. About 70.0% patients were obese, 54% of whom were classifed as having Class 3 obesity.

###### 

Demographic and clinical characteristics of study participants by gender (*n*=803)

  -------------------------------------------------------------------------------------------
  Variables                   Male (*n*=454)\   Female (*n*=349)\   *P*-Value   Total
                              *N* (%)           *N* (%)                         
  --------------------------- ----------------- ------------------- ----------- -------------
  Age (years) Mean±SD         44.9±15.9         47.2±15.6           0.04        45.9±15.9

  Weight (Kg) Mean±SD         99.8±30.9         96.6±27.5           0.13        98.4±29.5

  Height (cm) Mean±SD         167.0±12.8        156.5±10.2          \<0.0001    162.5±12.9

  BMI                                                                           

   Underweight                15 (60.0)         10 (40.0)           0.88        25 (31.0)

   Normal                     36 (65.5)         19 (34.5)           0.21        55 (6.8)

   Overweight                 110 (69.2)        49 (30.8)           \<0.0001    159 (19.8)

   Obese class 1              113 (72.9)        42 (27.1)           \<0.0001    155 (19.3)

   Obese class 2              62 (48.8)         65 (51.2)           0.07        127 (15.8)

   Obese class 3              118 (41.8)        164 (58.2)          \<0.0001    282 (35.1)

  HbA1c Mean±SD               6.55±1.6          6.5±1.6             0.54        6.5±1.6

  TG Mean±SD                  1.53±0.9          1.5±1.5             0.48        1.5±0.9

  HDL Mean±SD                 1.1±0.4           2.3±10.3            0.21        1.6±6.9

  LDL Mean±SD                 2.9±0.9           3.1±0.9             0.12        3.1±0.9

  Sleep AHI Mean±SD           23.5±23.1         16.9±18.9           \<0.0001    19.9±21.6

  Overall prevalence of OSA   359 (59.7)        242 (40.3)          0.002       601 (74.8)

  OSA severity                                                                  

   No OSA                     95 (47.0)         107 (53.0)          0.002       202 (25.2)

   Mild OSA                   137 (56.4)        106 (43.6)          0.95        243 (30.3)

   Moderate OSA               92 (55.1)         75 (44.9)           0.73        167 (20.8)

   Severe OSA                 130 (68.1)        61 (31.9)           \<0.0001    191 (23.8)

  Minimum O~2~ saturation\    82.6±10.9         82.5±10.9           0.95        82.42±10.95
  Mean±SD                                                                       
  -------------------------------------------------------------------------------------------

Values are presented as mean±SD or *n* (%). BMI=Body mass index, TG=Triglyceride, HbA1c=Glycosylated hemoglobin, HDL=High-density lipoprotein, LDL=Low-density lipoprotein, AHI=Apnea--hypopnea index, OSA=Obstructive sleep apnea, SD=Standard deviation

PSG data showed that 74.8% patients had OSA, with a mean AHI of 19.93 (±21.58) and mean minimum O~2~ saturation of 82.42 (±10.95). Males had a significantly higher percentage of OSA and mean AHI than the female patients \[[Table 1](#T1){ref-type="table"}\].

The prevalence of OSA was 77.7% among obese patients and 22.3% among non-obese patients; this was statistically significant, P-value \<0.0001 \[[Table 2](#T2){ref-type="table"}\] with a P\<0.001. The mean AHI was also significantly higher in obese (24.20 ± 22.86) than that in nonobese patients (12.11 ± 15.35). Furthermore, 50.1% of the obese patients who had OSA were classified as Class 3 obese.

###### 

Demographic and clinical characteristics of study participants by obesity (*n*=803)

  ----------------------------------------------------------------------------------
  Variables                  Non-obese (*n*=239)\   Obese (*n*=564)\   *P*-Value\*
                             *N* (%)                *N* (%)            
  -------------------------- ---------------------- ------------------ -------------
  Age (years) Mean±SD        44.34±15.63            46.55±15.92        0.073

  Sex                                                                  

   Male                      161 (35.5)             293 (64.5)         \<0.0001

   Female                    78 (22.3)              271 (77.7)         

  Weight (Kg) Mean±SD        69.69±13.07            110.53±25.95       \<0.0001

  Height (cm) Mean±SD        164.75±10.97           161.74±13.51       0.001

  BMI Mean±SD                24.78±5.59             43.72±20.24        \<0.0001

  HbA1c Mean±SD              6.52±1.63              6.50±1.60          0.935

  TG Mean±SD                 1.52±0.87              1.50±0.82          0.876

  HDL Mean±SD                1.23±0.59              1.7975±8.05        0.545

  LDL Mean±SD                2.94±0.92              3.09±0.96          0.194

  Sleep AHI Mean±SD          12.11±15.35            24.20±22.86        \<0.0001

  OSA                        134 (22.3)             467 (77.7)         \<0.0001

  OSA severity                                                         

   No OSA                    105 (52.0)             97 (48.0)          \<0.0001

   Mild OSA                  75 (30.9)              168 (69.1)         0.71

   Moderate OSA              31 (18.6)              136 (81.4)         0.001

   Severe OSA                28 (14.7)              163 (85.3)         \<0.0001

  Minimum O~2~ saturation\   83.43±10.80            82.20±10.96        0.166
  Mean±SD                                                              
  ----------------------------------------------------------------------------------

Values are presented as mean±SD or *n* (%). \**P* values were derived via independent *t*-test for categorical and continues variables, and Chi-square test for categorical variables. BMI=Body mass index, TG=Triglyceride, HbA1c=Glycosylated hemoglobin, HDL=High-density lipoprotein, LDL=Low-density lipoprotein, AHI=Apnea--hypopnea index, OSA=Obstructive sleep apnea, SD=Standard deviation

Regarding the severity of OSA, AHI was positively correlated with BMI (*P* \< 0.0001). About 85% of the patients with severe OSA were obese, compared to 14.7% who were non-obese, *P* \< 0.0001 \[[Table 2](#T2){ref-type="table"}\]. The patients in Obese category 3 had significantly higher body weight, BMI, and sleep AHI \[[Table 3](#T3){ref-type="table"}\]. Moreover, of the obese patients with severe OSA, 54% were classified as having Class 3 obesity \[[Table 4](#T4){ref-type="table"}\].

###### 

Comparison of demographic and clinical characteristics of study participants by different classes of obesity (*n*=566)

  -------------------------------------------------------------------------------------------------------------------------
  Variables                 Obese Class 1 (*n*=155)\   Obese Class 2 (*n*=127)\   Obese Class 3 (*n*=281)\   *P* -Value\*
                            Mean±SD                    Mean±SD                    Mean±SD                    
  ------------------------- -------------------------- -------------------------- -------------------------- --------------
  Age                       48.66±16.74                48.45±14.52                44.53±15.85                0.011

  Weight                    88.97±13.15                99.44±12.71                127.39±24.18               \<0.0001

  Height                    164.50±11.52               162.85±9.91                159.18±15.42               \<0.0001

  BMI                       32.32±1.42                 37.37±1.43                 52.85±25.41                \<0.0001

  HbA1c                     6.45±1.69                  6.76±1.68                  6.41±1.52                  0.273

  TG                        0.79±0.08                  0.80±0.10                  0.85±0.07                  0.679

  HDL                       0.37±0.04                  16.35±2.29                 0.66±0.07                  0.211

  LDL                       2.99±0.85                  3.26±1.10                  3.06±0.95                  0.220

  Sleep AHI                 21.48±19.24                21.12±21.47                27.08±24.92                0.011

  OSA                       127 (27.2)                 106 (22.7)                 234 (50.1)                 0.938

  Minimum O~2~ saturation   82.79±9.56                 81.44±11.91                82.22±11.267               0.611
  -------------------------------------------------------------------------------------------------------------------------

Values are presented as mean±SD or *n* (%). \**P* values were derived via one-way ANOVA for categorical and continues variables, and Chi-square test for categorical variables. BMI=Body mass index, TG=Triglyceride, HbA1c=Glycosylated hemoglobin, HDL=High-density lipoprotein, LDL=Low-density lipoprotein, AHI=Apnea--hypopnea index, OSA=Obstructive sleep apnea, SD=Standard deviation

###### 

Comparison between severity of obstructive sleep apnea and different classes of obesity (*n*=566)

  ---------------------------------------------------------------------------------------------------------------------------------------------
  OSA severity   Obese Class 1 (*n*=155)\   *P*-Value*\**   Obese Class 2 (*n*=127)\   *P*-Value*\**   Obese Class 3 (*n*=281)\   *P*-Value\*
                 *N* (%)                                    *N* (%)                                    *N* (%)                    
  -------------- -------------------------- --------------- -------------------------- --------------- -------------------------- -------------
  No OSA         28 (28.9)                  0.03            21 (21.6)                  0.02            48 (49.5)                  \<0.0001

  Mild OSA       46 (27.4)                  0.93            48 (28.6)                  0.05            74 (44.0)                  0.08

  Moderate OSA   40 (29.4)                  0.1             24 (17.6)                  0.64            72 (52.9)                  0.01

  Severe OSA     41 (25.2)                  0.44            34 (20.9)                  0.45            88 (54)                    \<0.0001
  ---------------------------------------------------------------------------------------------------------------------------------------------

Values are presented as mean±SD or *n* (%). \**P* values were derived via Chi-square test. OSA=Obstructive sleep apnea, SD=Standard deviation

Discussion {#sec1-4}
==========

The main purpose of this study was to explore the relationship between BMI and OSA and to develop an understanding of BMI as a risk factor for OSA incidence and severity. Majority (74.8%) of patients included in this study were diagnosed with OSA. Patients are sent for PSG testing based on a combination of symptoms and risk factors indicative of OSA, including daytime snoring, sleepiness, and obesity. Therefore, the proportion of OSA cases among the patients referred to sleep center are not expected to reflect the prevalence of the disease in the general population. One study found that snoring has a positive predictive value for OSA in 84.7% of the patients.\[[@ref13]\] Another study reported that snoring was a symptom in all the patients who experienced apnea while sleeping.\[[@ref8]\] Besides, obesity has been described by various studies as a major risk factor for OSA.\[[@ref14]\] Therefore, keeping in mind the commonality of snoring and obesity in our sample, a high prevalence of OSA was expected.

Another factor that may have contributed to the severity of OSA in our sample was the mean age (45.90 ± 15.86 years) of the patients. The sleep Heart Study conducted in 2002, reported that the prevalence and severity of OSA increased steadily with the age until 60 years of age when it reached a plateau.\[[@ref15]\] Furthermore, the study showed that males had a significantly higher prevalence of OSA and mean AHI than females. These findings are in agreement with previous reports that in general, males had a higher prevalence of OSA than females.\[[@ref16]\] In the present study, almost 30% of diagnosed males were found to have a severe form of OSA, which is in accordance with earlier studies.\[[@ref17]\] This can be associated with the higher prevalence of both obesity\[[@ref18]\] and snoring\[[@ref19]\] in males. Moreover, studies have shown that BMI is the best predictor for OSA in females, while neck circumference is a better risk predictor for males.\[[@ref8]\] However, the overall prevalence of OSA in morbidly obese women is still lower than that of males.\[[@ref17]\] This observation leads to the conclusion that regardless of age and weight, the female population, in general, has lower prevalence of OSA compared to the male population.\[[@ref20]\] The reasons for the differences between males and females are only partially understood; one of these reasons may be the difference in the structure and function of the upper airway in the sexes.\[[@ref20]\] Although the present study could not distinguish between the effects of BMI and neck circumference on sleep apnea in both sexes, it does underline the crucial effect of BMI on the risk of having OSA in both men and women.

The most relevant finding of this study was that the prevalence of OSA in obese patients was significantly higher than in nonobese patients. Moreover, AHI, a predictor for the severity of OSA, was found to be significantly higher in the obese population than that in the nonobese population. These findings suggest a positive correlation between obesity and the severity of OSA, as subjects with higher BMI scored higher AHI values on the PSG test. This result was expected as obesity is widely considered a risk factor for OSA and is thought to increase the severity of the syndrome. This effect of obesity on the severity of OSA may be caused by alterations in the normal airway functioning owing to excessive fat accumulation around the pharynx, leading to a reduction of the size of the airway passage.

Previous studies reported that there was a 32% increase in AHI score following an increase of 10% of body weight, leading to a 6-fold increase in the risk of developing severe OSA.\[[@ref16]\] The results of the present study are consistent with the findings of multiple past studies, including a Chinese study done in 2002, which reported a higher AHI score in subjects with higher body mass compared to subjects with lower body mass, with values of AHI smaller than five reported for patients with a mean BMI of 24.4 and AHI values of \>30 reported for patients with a mean BMI of 29.5.\[[@ref21][@ref22]\]

Similarly, a Turkish retrospective study conducted in 2011, which divided subjects into a control group (AHI \<5) and an OSA group (AHI \>5), found that the OSA group had a higher BMI (mean value of 32.15 ± 5.48) than the control group (mean value of 26.94 ± 5.1).\[[@ref5]\] Based on these results, we can infer a linear relationship between increasing body weight and AHI; the latter being an indicator of the severity of OSA and progression from mild to severe OSA.

Of our obese study subjects who were diagnosed with OSA, 50.1% were classified as having Class 3 obesity, with a BMI of \>39.99 kg/m^2^. This finding correlates well with the other results of our study which show an important linear relationship between obesity and OSA since OSA is more prevalent in subjects with greater BMI.\[[@ref5][@ref8][@ref17][@ref19][@ref20][@ref21][@ref22][@ref23]\] However, this apparent linear relationship between BMI and OSA could result from the fact that our sample (*n* = 803) contained 564 subjects classified as obese (70.2%), 282 of which (\~50% of the obese patients) were classified as Class 3 obese. Nevertheless, the results of the present study are in accordance with those of earlier studies which underscored the fact that higher BMI increased the risk of OSA.

A study conducted in the UK in 2012 among 50 years or older patients diagnosed with OSA, reported that of all of the obese subjects diagnosed with OSA during the period of their study, only 21.1% were classified with Class 3 obesity.\[[@ref24]\] The difference in the results of UK study and our study may reflect disparities in the lifestyle and the obesity prevalence in Saudi Arabia (35.4%)\[[@ref4]\] and England (25%).\[[@ref25]\] In general, we can infer that OSA prevalence and its severity are higher in morbidly obese patients, which would represent a greater fraction of samples taken from countries with a prevalence of obesity.

Our study had a few limitations with regard to incomplete documentation. Many of the patients our hospital regularly admits do not return for follow-up, so there are always issues with missing data. Other limitations include inaccurate data from records and lack of information about ethnicity.

Conclusion {#sec1-5}
==========

There was significantly greater prevalence and severity of OSA in obese patients compared to nonobese patients, particularly in males. Furthermore, the majority of patients with severe OSA were classified with Class 3 obesity. Therefore, obesity is a considerable risk factor for the development of OSA and could play a major role in increasing the severity of the disease. We encourage further studies on the impact of sedentary lifestyle and its association with OSA in Saudi Arabia, with an emphasis on the evaluation of the burden of the disease.
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